Neuca takes over Exom
Clinscience, a subsidiary of Neuca, buys 100 % of shares of the Italian Exom Group. Effective September 28, 2021, Cliniscience…
Clinscience, a subsidiary of Neuca, buys 100 % of shares of the Italian Exom Group. Effective September 28, 2021, Cliniscience…
Krzysztof Miszewski has become the new vice-president of Neuca, the company announced in a statement. He will be responsible for…
After the investments in Germany and Ukraine, the Polish network of clinical trials centres is also starting to operate in…
The Polish network of clinical trials centres – Pratia, a member of the Neuca Group, has acquired a 40% stake…
Pratia, a member of the Neuca Group, acquired 100% of shares in Examen, a company specialising in oncology and haematology…
Neuca Group, One of the largest pharmaceutical distributors in Poland, plans to invest in 2019. PLN 120 million. It will…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.